Literature DB >> 11932310

GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis.

Gudmundur Johannsson1, Yrsa Bergmann Sverrisdóttir, Lars Ellegård, Per-Arne Lundberg, Hans Herlitz.   

Abstract

Although sodium retention and volume expansion occur during GH administration, blood pressure is decreased or unchanged. The aim was to study the effect of short- and long-term GH replacement in adults on sodium balance, renal hemodynamics, and blood pressure. Ten adults with severe GH deficiency were included into a 7-d, randomized, placebo-controlled, cross-over trial followed by 12 months of open GH replacement. All measurements were performed under metabolic ward conditions. Extracellular water (ECW) was determined using multifrequency bioelectrical impedance analysis. Renal plasma flow and glomerular filtration rate were assessed using renal paraminohippurate and Cr(51) EDTA clearances, respectively. Renal tubular sodium reabsorption was assessed using lithium clearance. Plasma renin activity (PRA), plasma concentrations of angiotensin II, aldosterone, atrial natriuretic peptides and brain natriuretic peptides (BNP) and 24-h urinary norepinephrine excretion were measured. Seven days of GH treatment decreased urinary sodium excretion. Lithium clearance as a marker of proximal renal tubular sodium reabsorption was unaffected by GH treatment. ECW was increased after both short- and long-term treatment. This increase was inversely correlated to the decrease in diastolic blood pressure (r = -0.70, P = 0.02) between baseline and 12 months. Short-term treatment increased PRA and decreased BNP. The increase in PRA correlated with an increase in 24-h urinary norepinephrine excretion (r = 0.77, P < 0.01). Glomerular filtration rate and renal plasma flow did not change during treatment. The sodium- and water-retaining effect of GH takes place in the distal nephron. The sustained increase in ECW in response to GH is associated with an unchanged or decreased blood pressure. This together with unchanged or decreased atrial natriuretic peptides and BNP may prevent pressure-induced escape of sodium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11932310     DOI: 10.1210/jcem.87.4.8394

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  The use of hormonal growth factors in the treatment of patients with short-bowel syndrome.

Authors:  Palle B Jeppesen
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  The enigmatic role of growth hormone in age-related diseases, cognition, and longevity.

Authors:  Gabriela Colon; Tatiana Saccon; Augusto Schneider; Marcelo B Cavalcante; Derek M Huffman; Darlene Berryman; Ed List; Yuji Ikeno; Nicolas Musi; Andrzej Bartke; John Kopchick; James L Kirkland; Tamara Tchkonia; Michal M Masternak
Journal:  Geroscience       Date:  2019-09-04       Impact factor: 7.713

Review 3.  Diagnosis and treatment of growth hormone deficiency in adults.

Authors:  Atil Y Kargi; George R Merriam
Journal:  Nat Rev Endocrinol       Date:  2013-04-30       Impact factor: 43.330

Review 4.  The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathy.

Authors:  P Anil Kumar; Frank C Brosius; Ram K Menon
Journal:  Curr Diabetes Rev       Date:  2011-01

Review 5.  Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer.

Authors:  John J Kopchick; Reetobrata Basu; Darlene E Berryman; Jens O L Jorgensen; Gudmundur Johannsson; Vishwajeet Puri
Journal:  Nat Rev Endocrinol       Date:  2022-06-24       Impact factor: 47.564

6.  Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly.

Authors:  Peter Kamenicky; Say Viengchareun; Anne Blanchard; Geri Meduri; Philippe Zizzari; Martine Imbert-Teboul; Alain Doucet; Philippe Chanson; Marc Lombès
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

7.  Short-term effects of growth hormone treatment on the upper airways of non severely obese children with Prader-Willi syndrome.

Authors:  A Salvatoni; E Veronelli; L Nosetti; J Berini; S de Simone; L Iughetti; L Bosio; G Chiumello; G Grugni; G Delù; P Castelnuovo; G Trifirò; L Nespoli
Journal:  J Endocrinol Invest       Date:  2009-05-15       Impact factor: 4.256

Review 8.  Effects of GH and insulin-like growth factor-I on body composition.

Authors:  J Svensson; L Lönn; G Johannsson; B A Bengtsson
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

9.  LEAP-2/ghrelin interplay in adult growth hormone deficiency: Cause or consequence? A pilot study.

Authors:  Edoardo Vergani; Carmine Bruno; Cesare Gavotti; Luigi Simone Aversa; Maria Martire; Antonio Mancini; Diego Currò
Journal:  IUBMB Life       Date:  2021-05-28       Impact factor: 3.885

Review 10.  Hypertension in children with chronic kidney disease: pathophysiology and management.

Authors:  Charlotte Hadtstein; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2007-11-08       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.